n-Lorem Foundation

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
n-Lorem is focused on creating individual treatments for patients in the United States with ultra-rare diseases caused by genetic mutations that affect approximately n1-10 patients in the world. Diseases or conditions with broader patent populations are likely more suitable for treatment by other non-profit or for-profit entities, which we encourage you to explore with your physician.

With a seasoned leadership team and strategic partnerships, the n-Lorem Foundation provides the framework, funds and access for patients with ultra-rare diseases to receive experimental Antisense oligonucleotides (ASOs).
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Founder, CEO and Chairman of the Board
n-Lorem Foundation